| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MACROGENICS INC | Director | Common Stock | 37.6K | $685K | $18.22 | May 20, 2024 | Direct |
| MACROGENICS INC | Director | Stock Option (right to buy) | 16.5K | $167K | $10.15 | May 21, 2024 | Direct |
| MACROGENICS INC | Director | Restricted Stock Unit | 6.5K | $118K | $18.22 | May 21, 2024 | Direct |
| Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 25.1K | May 22, 2024 | Direct | ||
| APPLIED GENETIC TECHNOLOGIES CORP | Director | Common Stock | 0 | $0.77 | Nov 30, 2022 | By Hurwitz/Lichtenfeld Revocable Trust | |
| APPLIED GENETIC TECHNOLOGIES CORP | Director | Common Stock | 0 | $0.77 | Nov 30, 2022 | Direct | |
| APPLIED GENETIC TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 0 | Nov 30, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| MGNX | MACROGENICS INC | May 21, 2024 | 2 | $0 | 4 | May 23, 2024 | Director |
| MGNX | MACROGENICS INC | May 20, 2024 | 2 | $0 | 4 | May 22, 2024 | Director |
| MGNX | MACROGENICS INC | Aug 30, 2023 | 1 | $73.7K | 4 | Sep 1, 2023 | Director |
| MGNX | MACROGENICS INC | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
| DYN | Dyne Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2022 | 11 | $0 | 4 | Dec 1, 2022 | Director |
| DYN | Dyne Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
| MGNX | MACROGENICS INC | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2021 | 1 | $0 | 4 | Dec 2, 2021 | Director |
| DYN | Dyne Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |
| MGNX | MACROGENICS INC | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director |